Cypress Capital, LLC Bristol Myers Squibb CO Transaction History

Cypress Capital, LLC

$388 Billion
Q3 2024

A detailed history of Cypress Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cypress Capital, LLC holds 37,895 shares of BMY stock, worth $2.15 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

37,895

Holding current value

$2.15 Million

% of portfolio

0.51%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $1.5 Million - $1.96 Million	37,895 New	37,895 $1.96 Billion
Q2 2024 Aug 22, 2024	BUY	$40.25 - $52.99 $50,876 - $66,979	1,264 Added 3.76%	34,881 $1.45 Million
Q1 2024 Oct 29, 2024	BUY	$47.98 - $54.4 $1.61 Million - $1.83 Million	33,647 New	33,647 $1.82 Million
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $54,491 - $65,023	1,124 Added 3.46%	33,617 $1.72 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $34,618 - $38,708	-598 Reduced 1.81%	32,493 $1.89 Million
Q2 2023 Aug 07, 2023	BUY	$63.71 - $70.74 $53,325 - $59,209	837 Added 2.6%	33,091 $2.12 Million
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $56,379 - $63,946	858 Added 2.73%	32,254 $2.24 Million
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $19,242 - $22,786	281 Added 0.9%	31,396 $2.26 Million
Q3 2022 Feb 01, 2023	BUY	$0.13 - $76.84 $295 - $174,657	2,273 Added 7.88%	31,115 $2.21 Million
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $98,472 - $108,452	1,356 Added 4.93%	28,842 $2.22 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $60,496 - $72,540	984 Added 3.71%	27,486 $2.01 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $45,692 - $53,267	852 Added 3.32%	26,502 $1.65 Million
Q3 2021 Feb 10, 2022	BUY	$59.17 - $69.31 $133,960 - $156,917	2,264 Added 9.68%	25,650 $1.52 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $203,436 - $221,542	3,286 Added 16.35%	23,386 $1.56 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $93,163 - $104,781	1,570 Added 8.47%	20,100 $1.27 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $11,778 - $13,347	-204 Reduced 1.09%	18,530 $1.15 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $12,117 - $13,428	-211 Reduced 1.11%	18,734 $1.14 Million
Q2 2020 Aug 20, 2020	BUY	$54.82 - $64.09 $174,492 - $203,998	3,183 Added 20.19%	18,945 $1.11 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $51,473 - $67,142	1,046 Added 7.11%	15,762 $1.01 Million
Q3 2019 Nov 21, 2019	BUY	$42.77 - $50.71 $54,488 - $64,604	1,274 Added 9.48%	14,716 $746,000
Q2 2019 Jul 11, 2019	BUY	$44.62 - $49.34 $36,900 - $40,804	827 Added 6.56%	13,442 $609,000
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $57,708 - $68,810	1,279 Added 11.28%	12,615 $602,000
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $552,743 - $716,775	11,336 New	11,336 $589,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital, LLC with notifications on news.

Account

Cypress Capital, LLC Bristol Myers Squibb CO Transaction History